Vertex Pharmaceuticals (Europe's Net Worth
Vertex Pharmaceuticals (Europe's net worth is estimated to be at least $3,700,717.86 as of 11/23/2024. CoreStreet's estimation of Vertex Pharmaceuticals (Europe's net worth is based on their sale of stock and current holding of stock.
Vertex Pharmaceuticals (Europe is Major Shareholder at Crispr Therapeutics AG. They have executed at least 3 trades of stock as per SEC Form 4 filings. Their most recent trade was for 40,198 units of CRSP stock on 12/27/2018. Their biggest sale was on when they sold units of stock for $. They typically trade 3 times per year.
Total value of insider buys:
- $3,700,717.86
Total value of insider sells:
- $0.00
Most recent insider trade:
- Dec. 27, 2018
Vertex Pharmaceuticals (Europe's Insider Trading History
| Crispr Therapeutics AG | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 27, 2018 | Major Shareholder | 40,198 | $24.93 | Buy | $1,002,136.14 |
Dec. 24, 2018 | Major Shareholder | 90,742 | $24.08 | Buy | $2,185,067.36 |
Dec. 21, 2018 | Major Shareholder | 22,742 | $22.58 | Buy | $513,514.36 |